BioSpace News Archive

On the eve of the 43rd federal election, the Canadian Medical Association is reminding Canadians to exercise their democratic right and vote.

TLC, a clinical-stage specialty pharmaceutical company dedicated to the development and commercialization of novel nanomedicines designed to target areas of unmet medical need in pain management, ophthalmology and oncology, announced the appointment of Vincent Chang, PhD, as TLC’s Vice President of Manufacturing Development.

Innovent Biologics, Inc. announced positive updated results from the Incyte-sponsored Phase 2 trial of pemigatinib in patients with previously treated, advanced cholangiocarcinoma which were presented at the European Society for Medical Oncology 2019.